The name Hims & Hers Health Inc. (HIMS) should be kept on your radar

In the latest session, Hims & Hers Health Inc. (NYSE: HIMS) closed at $7.64 up 0.13% from its previous closing price of $7.63. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 1637151 shares were traded. HIMS stock price reached its highest trading level at $7.95 during the session, while it also had its lowest trading level at $7.53.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

For a deeper understanding of Hims & Hers Health Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On November 08, 2022, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7.50 to $8.50.

Piper Sandler Downgraded its Overweight to Neutral on October 17, 2022, whereas the target price for the stock was revised from $8 to $6.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 17 when Boughton Soleil sold 2,000 shares for $7.51 per share. The transaction valued at 15,020 led to the insider holds 287,089 shares of the business.

Boughton Soleil sold 12,345 shares of HIMS for $80,242 on Jan 03. The Chief Legal Officer now owns 289,089 shares after completing the transaction at $6.50 per share. On Dec 19, another insider, Boughton Soleil, who serves as the Chief Legal Officer of the company, sold 13,744 shares for $6.72 each. As a result, the insider received 92,360 and left with 301,434 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 5.03.

Stock Price History:

Over the past 52 weeks, HIMS has reached a high of $7.97, while it has fallen to a 52-week low of $2.72. The 50-Day Moving Average of the stock is 6.56, while the 200-Day Moving Average is calculated to be 5.45.

Shares Statistics:

For the past three months, HIMS has traded an average of 1.75M shares per day and 1.51M over the past ten days. A total of 205.23M shares are outstanding, with a floating share count of 155.83M. Insiders hold about 0.80% of the company’s shares, while institutions hold 58.20% stake in the company. Shares short for HIMS as of Oct 13, 2022 were 13.93M with a Short Ratio of 16.16M, compared to 13.64M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.73% and a Short% of Float of 11.46%.

Earnings Estimates

There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.11, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.34 and -$0.36 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.16, with 6 analysts recommending between $0.22 and -$0.27.

Revenue Estimates

A total of 9 analysts have provided revenue estimates for HIMS’s current fiscal year. The highest revenue estimate was $483.76M, while the lowest revenue estimate was $472.8M, resulting in an average revenue estimate of $479.9M. In the same quarter a year ago, actual revenue was $271.88M, up 76.50% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $635.77M in the next fiscal year. The high estimate is $682.63M and the low estimate is $572.8M. The average revenue growth estimate for next year is up 32.50% from the average revenue estimate for this year.